Xiao Jia Cai
Oprichter bij Thornton Consulting Group
Actieve functies van Xiao Jia Cai
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Thornton Consulting Group | Oprichter | - | - |
President | - | - | |
Spectral MD, Inc.
Spectral MD, Inc. Pharmaceuticals: MajorHealth Technology Spectral MD, Inc. engages in the manufacture of medical devices. It focuses on the modernization of wound care offering DeepView a wound imaging system. The company was founded by J. Michael DiMaio and is headquartered in Dallas, TX. | Directeur/Bestuurslid | - | - |
F5 Therapeutics, Inc. | Directeur/Bestuurslid | - | - |
AceLink Therapeutics, Inc.
AceLink Therapeutics, Inc. BiotechnologyHealth Technology AceLink Therapeutics, Inc. is a biopharmaceutical startup founded in 2018 that focuses on developing safe and effective medicines to address genetic diseases with high unmet needs. AceLink Therapeutics is based in Newark, CA. The private company's initial focus is on developing novel therapeutics for Fabry disease and type 1 Gaucher disease. The company was founded in 2018 by Wen Chen, Marvin R. Garovoy, and Jerry Shen. Jerry Shen has been the CEO since 2018. | Directeur/Bestuurslid | - | - |
Exarta Therapeutics | Directeur/Bestuurslid | - | - |
Amberstone Biosciences, Inc.
Amberstone Biosciences, Inc. BiotechnologyHealth Technology Amberstone Biosciences, Inc. is a company that aims to eliminate the issues of dose toxicity interfering with drug efficacy by introducing a safer class of therapeutic agents. The company is based in Laguna Hills, CA. The company's team of scientists and engineers strives to discover and develop transformative immunotherapeutics, pioneering a new wave of therapeutic breakthroughs. The company is developing first-in-class tumor microenvironment activated therapeutic (T-MATE). The company was founded in 2018 by Guikai George Wu. Guikai George Wu has been the CEO since 2018. | Directeur/Bestuurslid | - | - |
Science History Institute | Directeur/Bestuurslid | - | - |
Basking Biosciences, Inc.
Basking Biosciences, Inc. BiotechnologyHealth Technology Basking Biosciences, Inc. is a clinical-stage company that aims to solve the biggest need in ischemic stroke therapy. The company is based in Columbus, OH. The company is developing a first-in-class RNA aptamer targeting von Willebrand factor (vWF), an important structural component of blood clots and driver of the clotting process. Basking is also developing a complementary rapid-acting reversal oligonucleotide capable of quickly neutralizing the pharmacological activity of the RNA aptamer. The company has successfully completed a phase 1 single-ascending dose safety study and is initiating a phase 2 clinical proof-of-concept study in patients suffering from an acute ischemic stroke. The ultimate goal is to extend the therapeutic window for thrombolysis compared to currently approved therapies. Basking Biosciences was founded in 2019 by Shahid Nimjee, Bruce A. Sullenger, and Richard J. Shea has been the CEO of the company since 2019. | Directeur/Bestuurslid | - | - |
Loopbaan van Xiao Jia Cai
Eerdere bekende functies van Xiao Jia Cai
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
SPECTRAL AI, INC. | Directeur/Bestuurslid | 11-09-2023 | 14-05-2024 |
Independent Dir/Board Member | 11-09-2023 | 14-05-2024 | |
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░ ░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | - | - |
Opleiding van Xiao Jia Cai
University of Pennsylvania | Masters Business Admin |
University of Massachusetts | Doctorate Degree |
Tsinghua University | Graduate Degree |
Statistieken
Internationaal
Verenigde Staten | 14 |
China | 2 |
Verenigd Koninkrijk | 2 |
Operationeel
Director/Board Member | 10 |
Independent Dir/Board Member | 2 |
Graduate Degree | 1 |
Sectoraal
Health Technology | 8 |
Consumer Services | 4 |
Process Industries | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
AGILENT TECHNOLOGIES, INC. | Health Technology |
SPECTRAL AI, INC. | Health Technology |
Bedrijven in privébezit | 10 |
---|---|
Science History Institute | Process Industries |
Arthrosi Therapeutics, Inc.
Arthrosi Therapeutics, Inc. BiotechnologyHealth Technology Arthrosi Therapeutics, Inc. engages in the development of biotechnology treatment. The company was founded in 2017 and is headquartered in Laguna Hills, CA. | Health Technology |
Spectral MD, Inc.
Spectral MD, Inc. Pharmaceuticals: MajorHealth Technology Spectral MD, Inc. engages in the manufacture of medical devices. It focuses on the modernization of wound care offering DeepView a wound imaging system. The company was founded by J. Michael DiMaio and is headquartered in Dallas, TX. | Health Technology |
Basking Biosciences, Inc.
Basking Biosciences, Inc. BiotechnologyHealth Technology Basking Biosciences, Inc. is a clinical-stage company that aims to solve the biggest need in ischemic stroke therapy. The company is based in Columbus, OH. The company is developing a first-in-class RNA aptamer targeting von Willebrand factor (vWF), an important structural component of blood clots and driver of the clotting process. Basking is also developing a complementary rapid-acting reversal oligonucleotide capable of quickly neutralizing the pharmacological activity of the RNA aptamer. The company has successfully completed a phase 1 single-ascending dose safety study and is initiating a phase 2 clinical proof-of-concept study in patients suffering from an acute ischemic stroke. The ultimate goal is to extend the therapeutic window for thrombolysis compared to currently approved therapies. Basking Biosciences was founded in 2019 by Shahid Nimjee, Bruce A. Sullenger, and Richard J. Shea has been the CEO of the company since 2019. | Health Technology |
Spectral MD Holdings Ltd.
Spectral MD Holdings Ltd. Packaged SoftwareTechnology Services Spectral MD Holdings Ltd. develops proprietary artificial intelligence algorithms and optical technology to help clinicians to make faster treatment decisions in wound care sector. Its DeepView Wound Imaging solution is an internally developed AI and multispectral imaging technology that enables the user to distinguish between damaged and healthy human tissue. The company was founded in 2009 and is headquartered in Dallas, TX. | Technology Services |
Amberstone Biosciences, Inc.
Amberstone Biosciences, Inc. BiotechnologyHealth Technology Amberstone Biosciences, Inc. is a company that aims to eliminate the issues of dose toxicity interfering with drug efficacy by introducing a safer class of therapeutic agents. The company is based in Laguna Hills, CA. The company's team of scientists and engineers strives to discover and develop transformative immunotherapeutics, pioneering a new wave of therapeutic breakthroughs. The company is developing first-in-class tumor microenvironment activated therapeutic (T-MATE). The company was founded in 2018 by Guikai George Wu. Guikai George Wu has been the CEO since 2018. | Health Technology |
AceLink Therapeutics, Inc.
AceLink Therapeutics, Inc. BiotechnologyHealth Technology AceLink Therapeutics, Inc. is a biopharmaceutical startup founded in 2018 that focuses on developing safe and effective medicines to address genetic diseases with high unmet needs. AceLink Therapeutics is based in Newark, CA. The private company's initial focus is on developing novel therapeutics for Fabry disease and type 1 Gaucher disease. The company was founded in 2018 by Wen Chen, Marvin R. Garovoy, and Jerry Shen. Jerry Shen has been the CEO since 2018. | Health Technology |
Thornton Consulting Group | |
F5 Therapeutics, Inc. | |
Exarta Therapeutics |
- Beurs
- Insiders
- Xiao Jia Cai
- Ervaring